Scientists by trade. Explorers at heart.
3000+ people. More than 20 global locations. One expert team. Everything we do—from the services we offer to the products we provide—is made possible by our people. Our team of experts, innovators and leaders has helped hundreds of clients navigate complex R&D and manufacturing challenges. Now, we await yours.
A team you can count on
Quality and regulatory specialists
Our leadership team
Discover the latest from our thought leaders
The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate from formulation development to clinical phase production and commercial manufacturing can be daunting. Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill-finish is successful.